scispace - formally typeset
T

Taylor J. Jensen

Researcher at University of Arizona

Publications -  42
Citations -  1612

Taylor J. Jensen is an academic researcher from University of Arizona. The author has contributed to research in topics: Cancer & Epigenetics. The author has an hindex of 16, co-authored 28 publications receiving 1456 citations. Previous affiliations of Taylor J. Jensen include Sequenom, Inc..

Papers
More filters
Journal ArticleDOI

Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells.

TL;DR: It is reported that DNA methylation plays a role in the normal cell type-specific expression ofmiR-200c and miR-141 and this role appears evolutionarily conserved, since similar results were obtained in mouse.
Journal ArticleDOI

Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts

TL;DR: A novel method, referred to as SeqFF, for estimating the fetal DNA fraction in the plasma of pregnant women and to infer the underlying mechanism that allows for such statistical modeling is introduced.
Journal ArticleDOI

Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer

TL;DR: A high-resolution promoter tiling array approach is used to analyze DNA methylation in breast cancer specimens and normal breast tissue to suggest that agglomerative epigenetic aberrations are frequent events in human breast cancer.
Journal ArticleDOI

Epigenetic remodeling during arsenical-induced malignant transformation

TL;DR: Changes in histone H3 acetylation occur during arsenical-induced malignant transformation that are linked to the expression state of the associated gene and suggest that arsenicals may participate in tumorigenesis by altering the epigenetic terrain of select genes.
Journal ArticleDOI

Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization

TL;DR: Results show that large-scale epigenetic remodeling occurs in the earliest steps of mammary carcinogenesis, temporally links DNA methylation changes and overcoming cellular proliferation barriers, and provides a bank of potential epigenetic biomarkers that may prove useful in breast cancer risk assessment.